Snoring vs. Sleep Apnea: When Is Snoring a Warning Sign?

Snoring and sleep apnea overlap, but snoring alone can't diagnose OSA. Learn which warning signs can make evaluation more reasonable and what the diagnostic process typically includes.

Not medically reviewed. This article was written by The Snooze Lab editorial team using publicly available clinical guidance from the American Academy of Sleep Medicine (AASM), the U.S. Preventive Services Task Force (USPSTF), the American Thoracic Society (ATS), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), the National Heart, Lung, and Blood Institute (NHLBI/NIH), the FDA's own 510(k) clearance record, and the Centers for Disease Control and Prevention (CDC), along with peer-reviewed research including a JAMA Rational Clinical Examination systematic review, a meta-regression on snoring acoustics, and an individual-participant-data meta-analysis on obesity and OSA. It has not been reviewed by a licensed clinician. Read more about how we research.

Key Takeaways

  • Snoring and obstructive sleep apnea (OSA) overlap, but snoring alone is a weak signal — it's neither required for an OSA diagnosis nor enough, by itself, to establish one.
  • Concern rises mainly when snoring occurs alongside witnessed breathing pauses, gasping or choking, meaningful daytime sleepiness, repeated unintentional dozing, or sleepiness that affects safety-critical activities like driving.
  • You can have OSA without loud, obvious snoring, and louder snoring doesn't reliably mean more severe OSA.
  • Body weight raises OSA risk at a population level, but OSA occurs across all body sizes — weight alone can't confirm or rule out an individual diagnosis.
  • STOP-Bang can help estimate OSA risk, the Epworth Sleepiness Scale measures self-reported tendency to doze, and consumer risk-notification tools may flag patterns worth discussing with a clinician. None of these establishes an OSA diagnosis on its own.
  • OSA is diagnosed through a clinical evaluation plus objective testing — polysomnography, or home sleep apnea testing in appropriately selected adults — not from symptoms, screening scores, or wearable data alone.
  • If sleepiness is making it hard to stay awake while driving, treat that as an immediate safety concern, not a routine snoring question.

Snoring is common, and on its own it doesn’t tell you much. It becomes a more important question when it shows up alongside interrupted breathing, gasping or choking, real daytime sleepiness, or other risk factors that raise the odds of obstructive sleep apnea (OSA).

This article is about that distinction: what snoring can and can’t tell you, which accompanying signs make evaluation worth considering, and what the diagnostic process typically includes once you get there. It isn’t a guide to diagnosing yourself — that’s not something snoring, a questionnaire, or a wearable device can do.

Snoring and Sleep Apnea Are Not the Same Thing

Snoring is a sound: tissue in the throat vibrating as air squeezes past a narrowed airway during sleep. Our Why Do I Snore? guide covers what causes that narrowing in more depth, so this article won’t repeat it.

Obstructive sleep apnea is a diagnosed medical condition characterized by recurrent, predominantly obstructive respiratory events during sleep — the airway repeatedly narrows or closes, and breathing pauses or becomes markedly shallow. Those events often produce drops in oxygen, brief arousals, and fragmented sleep, but an oxygen drop isn’t a required feature of every single scored event. Many people who snore don’t have OSA. And — the part that trips people up most — not everyone with OSA snores loudly, or even snores in a way anyone’s noticed. The two conditions overlap. Neither one implies the other.

Snoring Alone Can’t Tell You Whether You Have Sleep Apnea

Snoring shows up often in people diagnosed with OSA, and clinicians treat it as one of several things worth asking about. But showing up often in people who have a condition is a different fact from being required for, or sufficient to establish, that diagnosis. Neither is true here. A person can have significant OSA with minimal or no reported snoring. A person can also snore loudly, every night, for years, without having OSA at all.

A 2013 systematic review in JAMA, pooling results across dozens of studies that all used full, attended polysomnography as the reference standard, looked at exactly this question: which findings from a clinical exam actually help identify OSA. Its conclusion lines up with everything above — snoring alone “is not useful for establishing the diagnosis.” Nocturnal gasping or choking, by contrast, was the single most informative finding the review identified from a clinical exam alone — still not enough to establish a diagnosis by itself, but meaningfully more useful than snoring. That’s part of why the list in the next section treats gasping and choking as a stronger reason for suspicion than snoring itself. (The review drew on a mix of community-screened populations, where OSA was less common, and people already referred for a sleep evaluation, where it was far more common — a reminder that how informative a finding is can depend on who’s being evaluated, not a fact to be read as a precise, individual probability.)

The NHLBI lists snoring among the signs that can accompany sleep apnea — not as a stand-alone marker of it. That lines up with how the American Academy of Sleep Medicine’s clinical practice guideline on diagnosing adult OSA treats the whole category of symptom-based shortcuts: it recommends, as a strong recommendation, against using “clinical tools, questionnaires, and prediction algorithms” to diagnose OSA in place of actual testing. A “do I snore, therefore do I have OSA” logic falls squarely into that category.

Snoring, on its own, is a cue that something might be worth looking into. It isn’t evidence that resolves the question either way.

What Makes Snoring More Concerning?

The features accompanying snoring are often more informative than snoring alone when deciding whether OSA should be considered. A handful of them, in particular, are what actually make “worth a conversation with a healthcare professional” the right framing. None of them, alone, proves OSA — but together, they’re the pattern clinicians actually look for:

  1. Witnessed breathing pauses. A bed partner (or anyone else in the room) noticing that breathing seems to stop for periods during sleep.
  2. Gasping or choking sounds during sleep. Often described as abrupt, startled-sounding breaths that interrupt the usual snoring pattern.
  3. Excessive daytime sleepiness. Not ordinary tiredness, but sleepiness substantial enough to interfere with normal daily activity. If your tiredness doesn’t clearly involve nodding off or struggling to stay alert, our guide to why you might still be tired after 8 hours of sleep covers the much wider range of possible explanations.
  4. Repeated unintentional dozing. Falling asleep without meaning to, especially in situations that should keep you reasonably alert.
  5. Sleepiness affecting driving or other safety-critical activity. This one is serious enough to deserve its own section below.
  6. Broader clinical context. Certain medical factors — such as resistant or poorly controlled hypertension and some cardiovascular conditions — may increase a clinician’s concern for OSA or affect whether evaluation is appropriate.

On that last point: OSA is common in several cardiovascular populations and has important cardiovascular associations. The American Heart Association’s 2021 scientific statement on OSA and cardiovascular disease reports that OSA shows up often among people who already have conditions including hypertension, heart failure, coronary artery disease, pulmonary hypertension, atrial fibrillation, or stroke, and recommends screening for OSA in people with resistant or poorly controlled hypertension, pulmonary hypertension, or recurrent atrial fibrillation specifically because of how often it co-occurs with those conditions. That’s a statement about prevalence across several distinct cardiovascular populations and clinical screening priorities — not a claim that OSA, let alone ordinary snoring itself, causes cardiovascular disease.

Other symptoms sometimes mentioned alongside OSA — morning headache, dry mouth, frequent nighttime urination, fragmented sleep, mood changes — show up in plenty of unrelated situations too. They’re worth mentioning to a healthcare provider as part of the overall picture, not read as standalone warning signs.

Sleep position is a separate, management-side question from everything in this article. Our guide to side sleeping covers what positional changes can and can't do for people with positional OSA specifically. This article is about recognizing when evaluation is worth considering — not about managing a diagnosis you already have.

Can You Have Sleep Apnea Without Loud Snoring?

Yes. The NHLBI notes that people often don’t realize they have symptoms of sleep apnea “until someone tells you” — which cuts both ways: the absence of a partner’s report of loud snoring isn’t the same as confirmation that nothing’s happening.

Quiet snorers, people who snore only occasionally, and people whose snoring hasn’t been noticed by anyone can still have clinically significant OSA. This is one of the more important corrections in this article: the absence of loud, obvious snoring is not reassurance that OSA is off the table. If the other signs above — witnessed pauses, gasping, meaningful daytime sleepiness — are present, they’re worth raising with a healthcare provider regardless of how quiet or occasional the snoring itself sounds.

Does Louder Snoring Mean Worse Sleep Apnea?

It’s a reasonable-sounding assumption: if the apnea is worse, the snoring should sound worse too. Research doesn’t back that up as a reliable individual-level signal.

A 2022 meta-regression analysis pooling 13 studies and 3,153 adults found a correlation of 0.71 between acoustic snoring measures and the apnea-hypopnea index — a number that, read alone, sounds like a meaningfully strong relationship. But the same analysis had very high between-study heterogeneity (I² ≈ 97.6%), meaning the individual studies’ own estimates of that relationship were highly inconsistent with each other — some found a much stronger link than others, for reasons the analysis couldn’t fully explain. That makes the group-level correlation unsuitable as an individual severity gauge: it’s a real pattern across research populations as a whole, not a reliable yardstick for any one person’s snoring. Tellingly, the same researchers’ own conclusion doesn’t treat their finding as a diagnostic shortcut: the study does not establish acoustic snoring measurements as a substitute for appropriate clinical evaluation and diagnostic testing.

In plain terms: snoring loudness isn’t a severity gauge for an individual. It’s not a reason to reassure yourself (“mine’s not that loud, so it’s probably fine”) or alarm yourself (“mine’s gotten so loud, it must be severe”).

What Does Body Weight Tell You?

Body weight is one of the most consistently cited risk factors for OSA, and that reputation is earned: higher body weight is associated with higher OSA risk at a population level. But a population-level risk factor is a different kind of fact from an individual diagnostic test, and the gap between the two matters here.

OSA is not an obesity-only condition. A 2025 individual-participant-data meta-analysis pooled four community-based cohort studies, covering 12,860 adults — not sleep-clinic referrals, but people recruited from the community regardless of whether they had any sleep complaint. The community cohorts included people with OSA who did not have obesity, reinforcing that obesity is an important risk factor but is not required for OSA. That’s a meaningfully different, and stronger, kind of evidence than a single clinic’s referral records, precisely because it isn’t limited to people who were already flagged for a sleep evaluation.

One honest limit on that evidence: the pooled cohort’s average age was considerably older than the general adult population, so this finding is best read as a solid demonstration that the obesity-only assumption is wrong, not as a statistic — of any frequency — to apply to adults generally. OSA risk and body-composition patterns both shift with age, and the qualitative point is what carries over: OSA occurs in people who aren’t obese, and obesity can’t be used as a gatekeeping assumption for who gets evaluated.

Body size, in either direction, doesn’t confirm or rule out OSA for a given person. It’s one factor among several that a clinician weighs, not a stand-in for testing.

Screening Is Not Diagnosis

Two tools come up often around sleep apnea, and it’s worth knowing what each one actually does, and doesn’t.

STOP-Bang is a short questionnaire covering eight factors: snoring, tiredness, observed breathing pauses, blood pressure, and four physical/demographic items (body mass index, age, neck size, and sex). As the clinician-researchers who developed and validated it describe it, the tool exists so that “patients can be classified for OSA risk based on their respective scores” — language about risk stratification, not diagnosis. The AASM’s own diagnostic guideline reinforces the same point from the other direction, stating as a strong recommendation that clinical tools and questionnaires like this one should not be used to diagnose OSA in the absence of actual testing. STOP-Bang helps identify people at higher risk who may warrant further evaluation — not a result to interpret on your own.

The Epworth Sleepiness Scale measures something different: your self-reported tendency to doze off across a set of everyday situations. A 2013 American Thoracic Society clinical practice guideline is direct about its limits: the score alone can neither confirm nor exclude sleepiness, and isn’t sufficient, by itself, to identify a high-risk driver. It’s a prompt for further conversation with a clinician, not a verdict.

Neither tool replaces testing, and neither produces a number meant for self-diagnosis. If a score from either one is relevant to your situation, that’s worth discussing with a healthcare provider alongside everything else in your history, rather than interpreting the number on its own.

It’s also worth separating two different questions that often get blurred together: should adults who are not presenting with recognized OSA symptoms or concerns be routinely screened, versus how should someone who presents with symptoms or concerns suggestive of OSA be evaluated. The USPSTF looked specifically at the first question, and in its current (2022) recommendation concluded that evidence is insufficient to recommend for or against routine screening in that population. That statement is explicit about its own scope: it “does not apply to persons presenting with symptoms or concerns about OSA, persons who have been referred for evaluation or treatment of suspected OSA.” In other words, “there isn’t enough evidence to justify a universal screening program” is a conclusion about population-level screening policy. It is not a statement that snoring plus the warning signs described above shouldn’t be evaluated in someone who actually raises them.

What About Smartwatches and Snoring Apps?

Consumer sleep-tracking devices and snoring apps have gotten more sophisticated, and at least one is now backed by real regulatory review rather than marketing claims alone. The clearest current example is Apple’s sleep apnea notification feature, which the FDA classifies as an over-the-counter device intended to assess risk, cleared in September 2024. The FDA’s own cleared indications-for-use statement, quoted directly from the clearance record, says the feature “analyzes Apple Watch sensor data to identify patterns of breathing disturbances suggestive of moderate-to-severe sleep apnea and provides a notification to the user,” is “intended for over-the-counter (OTC) use by adults age 18 and over who have not previously received a sleep apnea diagnosis,” and — in the same sentence — “is not intended to diagnose, treat, or aid in the management of sleep apnea.” The clearance record adds one sentence further that’s worth repeating verbatim: “The absence of a notification is not intended to indicate the absence of sleep apnea.” (Which specific watch models support this feature is a detail that changes with product cycles and isn’t load-bearing to the medical point here — check current manufacturer documentation if that matters to you.)

A notification is meant to prompt a conversation with a healthcare provider, not substitute for one — and no notification is not the same as a clean bill of health. Either way, the same appropriate clinical evaluation and testing described in this article remains the thing that actually resolves the question, regardless of what a device does or doesn’t flag.

Some consumer tools may flag patterns worth discussing with a clinician, but they should not be treated as diagnostic unless that specific product has an established diagnostic role and is being used for that intended purpose.

How Sleep Apnea Is Actually Diagnosed

Once snoring and its accompanying signs make evaluation reasonable, here’s what the diagnostic process typically includes. This isn’t a fixed script every patient follows in the same order — the right path depends on individual history, risk, and clinical judgment, and this section describes the general shape of that process rather than telling any specific reader which test applies to them.

It starts with a clinical evaluation: a healthcare provider takes a history (the symptoms above, risk factors, family history) and performs a physical exam. The AASM’s guideline treats this evaluation as a prerequisite, not an optional preliminary — testing is meant to happen in conjunction with a comprehensive evaluation, not instead of one.

From there, objective testing is what actually establishes the diagnosis:

  • Polysomnography (PSG). An in-lab, overnight sleep study that records brain activity, eye movements, muscle activity, heart rhythm, breathing effort and airflow, and blood oxygen levels. It’s the long-standing reference-standard test.
  • Home sleep apnea testing (HSAT). A more limited test done at home with a portable device, typically measuring breathing and oxygen levels without the brain-wave monitoring PSG includes. The AASM guideline supports HSAT specifically for uncomplicated adults who already present with signs indicating an increased risk of moderate-to-severe OSA — it’s positioned as appropriate for that specific group, not as a universal substitute for PSG in every situation.

HSAT has real limits. Because it generally can’t measure actual sleep time the way PSG can, it can underestimate how severe someone’s breathing problems are. AASM generally recommends proceeding to polysomnography, rather than simply repeating the same home test, after a negative, inconclusive, or technically inadequate HSAT — though the guideline acknowledges there are limited circumstances where a clinician and patient might choose a repeat HSAT instead. Which path applies in a given case is a clinical decision, not something a general article can tell you.

PSG commonly reports an apnea-hypopnea index (AHI), which relates respiratory events to hours of measured sleep. Home testing commonly reports a related but distinct measure, a respiratory event index (REI), which relates events to monitoring time or estimated sleep time instead. The two measures are closely related but not strictly interchangeable. Whichever measure is used, it’s central to how OSA severity gets classified, but it isn’t the entire clinical picture — how far oxygen levels drop, how fragmented sleep becomes, and how a person is actually functioning during the day all factor into a clinician’s overall assessment alongside the index number itself.

None of this is meant to tell you, personally, whether you need PSG or HSAT, or what a given result would mean for you. That depends on your specific history and belongs in a conversation with a healthcare provider, not a general article.

A Note on Children

Everything above is written for adults. Snoring and suspected OSA work differently in children and adolescents: pediatric OSA is most often tied to enlarged tonsils and adenoids, obesity, or both, and the American Academy of Pediatrics maintains its own clinical practice guideline for diagnosing and managing it in children — a separate framework from the adult guidance in this article. Pediatric OSA can also present differently than it does in adults, sometimes showing up as hyperactivity or attention problems rather than the kind of daytime sleepiness most adults describe. If a child snores regularly, that’s worth raising with their pediatrician using that pediatric framework, not the adult guidance covered here.

When Should You Talk to a Healthcare Professional?

Snoring by itself, even if it’s loud or has gone on for years, isn’t automatically a reason to seek an OSA evaluation. Evaluation becomes more reasonable when snoring occurs together with:

  • witnessed pauses in breathing during sleep
  • recurrent gasping or choking sounds
  • daytime sleepiness substantial enough to interfere with normal activities
  • repeated unintentional dozing
  • sleepiness that’s affecting driving or other safety-critical tasks
  • relevant risk context a clinician would weigh, such as treatment-resistant high blood pressure or other factors in your broader health history

Major diagnostic guidance does not use a simple nights-per-week snoring cutoff, by itself, to diagnose OSA or determine whether sleep testing is appropriate. If you come across a specific frequency threshold presented as a self-triage rule elsewhere, it’s worth treating it skeptically rather than as settled guidance. What actually matters is the pattern of accompanying signs above, and a healthcare provider is in a far better position than any article to weigh how your particular combination of symptoms and risk factors adds up.

If Sleepiness Is Affecting Your Driving

A 2013 American Thoracic Society clinical practice guideline on sleep apnea and driving risk put real numbers on this: OSA, versus not having it, is associated with a two- to three-times increased overall risk of a motor vehicle crash — but the guideline is equally direct that “prediction of risk in an individual is imprecise,” and that neither self-reported sleepiness nor an Epworth score nor body mass index, used alone, reliably identifies who is actually a high-risk driver. The guideline does use a specific “high-risk driver” category — moderate-to-severe daytime sleepiness combined with a recent crash or near-miss — but that category exists to decide how urgently a clinician should act once someone is already in care, such as how quickly to schedule testing. It is a clinical-management category, not a line that separates “safe to drive” from “unsafe to drive.” A separate 2025 AASM position statement reinforces the underlying point: sleepiness itself is “a critical patient-reported outcome” tied to real safety risk, not something to wave off as routine tiredness.

If you're struggling to stay awake while driving, pull over somewhere safe as soon as you can and do not continue driving while sleepy. That applies the first time it happens, not only after a crash or near-miss. If this is a recurring problem, bring it up with a healthcare provider, regardless of whether the underlying cause turns out to be sleep apnea; this is practical safety guidance, not a diagnosis, and not legal advice about your specific situation or obligations. A CDC analysis separately found that short sleep, snoring, and unintentional daytime dozing were each independently linked to a higher likelihood of having fallen asleep while driving in general, and that drowsy-driving crashes are more likely to cause injury or death than crashes that don't involve drowsiness.

Bottom Line

Snoring is a clue, not a diagnosis. On its own, it tells you very little about whether obstructive sleep apnea is part of the picture. Specific accompanying symptoms and risk factors can raise reasonable suspicion. STOP-Bang can estimate OSA risk, the Epworth Sleepiness Scale measures subjective sleepiness, and consumer risk-notification tools can flag a pattern worth discussing — but none of those results is an OSA diagnosis. Diagnosis comes from a clinical evaluation together with appropriate objective testing: polysomnography, or home sleep apnea testing in the adults it’s appropriate for. If that describes a conversation you’ve been putting off, especially if any of the breathing-pause, gasping, or significant-sleepiness signs above apply to you, it’s worth having. And if that conversation leads to a CPAP prescription, our guide to common CPAP problems and practical fixes covers the adjustment period.

Frequently Asked Questions

If I don't snore loudly, does that rule out sleep apnea?

No. People can have clinically significant obstructive sleep apnea with quiet, infrequent, or no reported snoring at all. The absence of loud snoring isn't reassurance on its own — the other signs discussed in this article (witnessed breathing pauses, gasping or choking, meaningful daytime sleepiness) matter more than how loud or quiet the snoring sounds.

Can a smartwatch or snoring app diagnose sleep apnea?

No. Even FDA-cleared features, like the Apple Watch sleep apnea notification, are designed to flag a pattern worth discussing with a healthcare provider, not to diagnose the condition. A negative wearable result does not rule OSA out. Clinical evaluation and appropriate diagnostic testing are used to determine whether OSA is present.

Do I need a sleep study just because I occasionally snore?

Not necessarily. Snoring by itself does not determine whether sleep testing is appropriate. A healthcare professional can consider the pattern of snoring together with symptoms, medical history, and other risk factors.

Is it safe to keep driving if I'm this sleepy?

No — treat significant sleepiness behind the wheel as an immediate safety issue. If you're struggling to stay awake while driving, pull over somewhere safe as soon as you can and do not continue driving while sleepy. If this is recurring, or you've had a near-miss from dozing off, talk with a healthcare provider. This matters regardless of whether the underlying cause turns out to be sleep apnea.

Sources

  1. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea(opens in a new tab)American Academy of Sleep Medicine (AASM) — Journal of Clinical Sleep Medicine 13(3):479-504 (Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K, Harrod CG), DOI 10.5664/jcsm.6506 · March 15, 2017Clinical guideline supporting the distinction between OSA screening and diagnosis, and explaining when polysomnography or home sleep apnea testing may be used.
  2. Does This Patient Have Obstructive Sleep Apnea? The Rational Clinical Examination Systematic Review(opens in a new tab)JAMA — JAMA 310(7):731-741 (Myers KA, Mrkobrada M, Simel DL), DOI 10.1001/jama.2013.276185, PMID 23989984 · August 21, 2013Systematic review supporting the distinction between snoring alone and more informative signs such as nocturnal gasping or choking, while emphasizing that symptoms cannot establish an OSA diagnosis by themselves.
  3. Correlation Between Snoring Sounds and Obstructive Sleep Apnea in Adults: A Meta-Regression Analysis(opens in a new tab)Sleep Science — Sleep Sci 15(4):463-470 (Chiang JK, Lin YC, Lu CM, Kao YH), DOI 10.5935/1984-0063.20220068 · December 2022Meta-analysis examining snoring acoustics and OSA severity, used to explain why group-level associations do not make snoring loudness a reliable severity gauge for an individual.
  4. The Relationship Between Obesity and Obstructive Sleep Apnea in Four Community-Based Cohorts: An Individual Participant Data Meta-Analysis of 12,860 Adults(opens in a new tab)EClinicalMedicine — EClinicalMedicine 83:103221 (Esmaeili N, et al.), DOI 10.1016/j.eclinm.2025.103221 · April 23, 2025Community-cohort meta-analysis supporting the point that higher body weight raises OSA risk but obesity is not required for OSA to occur.
  5. Screening for Obstructive Sleep Apnea in Adults: US Preventive Services Task Force Recommendation Statement(opens in a new tab)U.S. Preventive Services Task Force (USPSTF) — USPSTF · November 15, 2022Current USPSTF recommendation used to distinguish routine population screening from evaluation of people who present with symptoms or concerns about OSA.
  6. STOP-Bang Questionnaire: A Practical Approach to Screen for Obstructive Sleep Apnea(opens in a new tab)Chest — Chest 149(3):631-638 (Chung F, Abdullah HR, Liao P), PMID 26378880Clinical review describing STOP-Bang as a tool for estimating OSA risk rather than establishing a diagnosis.
  7. Sleep Apnea — Diagnosis(opens in a new tab)National Heart, Lung, and Blood Institute (NHLBI/NIH) — NHLBINIH overview of the clinical evaluation and objective testing used to diagnose sleep apnea.
  8. Sleep Apnea — Symptoms(opens in a new tab)National Heart, Lung, and Blood Institute (NHLBI/NIH) — NHLBINIH guidance on common OSA symptoms and warning signs, including witnessed breathing pauses, gasping, and daytime sleepiness.
  9. 510(k) Premarket Notification K240929 — Sleep Apnea Notification Feature (SANF)(opens in a new tab)U.S. Food and Drug Administration (FDA) — FDA Center for Devices and Radiological Health, Decision date September 13, 2024 · September 13, 2024FDA clearance record establishing that the Apple sleep apnea notification feature assesses risk and is not intended to diagnose, treat, or rule out sleep apnea.
  10. An Official American Thoracic Society Clinical Practice Guideline: Sleep Apnea, Sleepiness, and Driving Risk in Noncommercial Drivers(opens in a new tab)American Thoracic Society (ATS) — Am J Respir Crit Care Med 187(11):1259-1266 (Strohl KP, et al.), DOI 10.1164/rccm.201304-0726ST · June 1, 2013Clinical guideline supporting the discussion of OSA, excessive sleepiness, driving risk, and the limits of predicting driving risk from any single symptom or questionnaire score.
  11. Clinical Significance of Sleepiness: An American Academy of Sleep Medicine Position Statement(opens in a new tab)American Academy of Sleep Medicine (AASM) — J Clin Sleep Med 21(6):1103-1107 (Heffron TM, Gurubhagavatula I, Trotti LM, et al.), DOI 10.5664/jcsm.11658 · June 2025AASM position statement supporting the treatment of clinically important sleepiness as a patient-safety concern.
  12. Drowsy Driving — 19 States and the District of Columbia, 2009–2010(opens in a new tab)Centers for Disease Control and Prevention (CDC) — Morbidity and Mortality Weekly Report (MMWR) 61(51);1033-1037 · January 4, 2013Public-health data providing additional context on drowsy driving, unintentional daytime dozing, and crash risk.
  13. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association(opens in a new tab)American Heart Association (AHA) — Circulation 144(3):e56-e67 (Yeghiazarians Y, Jneid H, Tietjens JR, Redline S, Brown DL, El-Sherif N, Mehra R, Bozkurt B, Ndumele CE, Somers VK), DOI 10.1161/CIR.0000000000000988, PMID 34148375 · June 21, 2021Scientific statement supporting the article's restrained discussion of OSA's cardiovascular associations and relevant clinical contexts for evaluation.
  14. Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome(opens in a new tab)American Academy of Pediatrics (AAP) — Pediatrics 130(3):576-584 · August 27, 2012Pediatric clinical guidance supporting the article's boundary that children with suspected OSA require a separate evaluation framework from adults.

Medical disclaimer: this article is for general educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always talk to a qualified healthcare professional about your individual situation. Read our full medical disclaimer.